All news from Physical Medicine & Rehabilitation

Will Tarloxotinib Finally Break the HER2 Barrier in Lung Cancer?

The HER2 gene is a well-known driver of breast cancer, where changes in this gene are found in about 1-in-5 cases of the disease. HER2 also contributes to about 3 percent of lung cancers, representing about 6,500 patients per year. But while drugs like trastuzumab and lapatinib have proven effective in silencing the action of HER2 in breast cancer, there are currently no approved HER2-targeted therapies for the treatment of lung cancer

Interactive Shutter Eyeglasses to Replace Eyepatch Therapy

The standard treatment for a so-called lazy eye (amblyopia) in children is to cover the nonimpaired eye with a patch. This trains the impaired eye to work harder. Such therapy is successful only when the patient wears the eyepatch for the prescribed period of time. This is often not the case, however, as many children feel self-conscious about wearing the patch and reject this form of treatment

Bipolar Structure For Nerve Cell Migration

The cerebral cortex is responsible for a large number of complex brain functions, ranging from the perception of sensory stimuli through alertness, memory, and language to consciousness. Neurobiologists at the Max Planck Institute for Experimental Medicine in Göttingen have decoded a new regulatory principle that controls the development of the complex neuronal architecture in the cerebral cortex